Connect with us

Spain

Spain approves 'dose-sparing' of monkeypox vaccine

SHARE:

Published

4 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Two monkeypox cases are tested in a laboratory at La Paz Hospital, Madrid, Spain.

Spanish health authorities approved on Monday (22 August) a new monkeypox vaccination plan. This will allow more people to be vaccinated in smaller doses due to limited supplies.

The ministry stated that each dose of Bavarian Nordic’s (BAVA.CO Imvanex vaccine), the only available monkeypox vaccine, will be broken into five doses.

Spain's new strategy follows the lead of Britain. The European Medicines Agency has allowed "dose-sparing" since last week. Spain also approved smaller doses of monkeypox vaccine Monday.

Spain was given an additional 5,000 doses of vaccine on Monday. This brings the total to over 17,000 doses.

Spain has been among the worst-hit countries by the disease since May, when it registered more than 6,119 cases of monkeypox.

More than 40,000 cases of the disease have been reported worldwide in 80 countries that are not endemic.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending